title: Robotic-assisted surgery for primary or recurrent oropharyngeal carcinoma.
abstract: OBJECTIVE
  To determine the feasibility of robotic-assisted salvage surgery for oropharyngeal cancer.
  
  
  METHODS
  Retrospective case-controlled study.
  
  
  METHODS
  Academic, tertiary referral center.
  
  
  METHODS
  Patients who underwent surgical resection for T1 and T2 oropharyngeal cancer between 2001 and 2008 were classified into the following 3 groups based on type of resection: (1) robotic-assisted surgery for primary neoplasms (robotic primary) (n = 15), (2) robotic-assisted salvage surgery for recurrent disease (robotic salvage) (n = 7), and (3) open salvage resection for recurrent disease (n = 14).
  
  
  METHODS
  Data regarding tumor subsite, stage, and prior treatment were evaluated as well as margin status, nodal disease, length of hospital stay, diet, and tracheotomy tube dependence.
  
  
  RESULTS
  The median length of stay in the open salvage group was longer (8.2 days) than robotic salvage (5.0 days) (P = .14) and robotic primary (1.5 days) resection groups (P < .001). There was no difference in postoperative diet between robotic primary and robotic salvage surgery groups. However, a greater proportion of patients who underwent open salvage procedures were gastrostomy tube dependent 6 months following treatment (43%) compared with robotic salvage resection (0%) (P = .06). A greater proportion of patients who underwent open salvage procedures also remained tracheotomy tube dependent after 6 months (7%) compared with robotic salvage or robotic primary patients (0%) (P = .48). No complications were reported in the robotic salvage group. Two patients who underwent open salvage resection developed postoperative hematomas and 2 developed wound infections.
  
  
  CONCLUSIONS
  When feasible, robotic-assisted surgery is an acceptable procedure for resection of both primary and recurrent oropharyngeal tumors. Trial Registration clinicaltrials.gov Identifier: NCT00473564.
authors.affiliation: Department of Surgery, University of Alabama at Birmingham, USA.
authors.forename: Nichole R
authors.initials: NR
authors.lastname: Dean
authors.forename: Eben L
authors.initials: EL
authors.lastname: Rosenthal
authors.forename: William R
authors.initials: WR
authors.lastname: Carroll
authors.forename: John P
authors.initials: JP
authors.lastname: Kostrzewa
authors.forename: Virginia L
authors.initials: VL
authors.lastname: Jones
authors.forename: Renee' A
authors.initials: RA
authors.lastname: Desmond
authors.forename: Lisa
authors.initials: L
authors.lastname: Clemons
authors.forename: J Scott
authors.initials: JS
authors.lastname: Magnuson
mesh_terms: D000328:Adult; D000368:Aged; D018277:Carcinoma, Mucoepidermoid / Q000473:pathology / Q000601:surgery*; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000601:surgery*; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000601:surgery*; D009367:Neoplasm Staging; D009959:Oropharyngeal Neoplasms / Q000473:pathology* / Q000601:surgery*; D012189:Retrospective Studies; D012371:Robotics; D016879:Salvage Therapy / Q000295:instrumentation; D016896:Treatment Outcome